Nerve
biologic products include artificial nerve conduit, nerve graft,
nerve wraps, or nerve capping devices used for guiding axonal
regrowth to facilitate nerve regeneration. These devices are majorly
used in clinical treatments for nerve injuries. Nerve biologic
products are commonly used for complex suturing, for instance
suturing of two ends of a separated nerve that needs rigid process.
The scaffold material used for generating nerve biologic products is
either from synthetic or biological origin. The nerve biologic
products are manufactured from various biocompatible products such as
polysialic acid (PSA), collagen type I/III, spider silk fiber,
silkworm silk fibroin, chitosan, aragonite, and alginate.
Request
Sample of Report:
https://www.coherentmarketinsights.com/insight/request-sample/2265
Nerve
Biologic Products Market Drivers
Advancements
in research and development for developing innovative technology for
nerve biologic products are expected to drive growth of the nerve
biologic product market. For instance, in February 2015, researchers
from the University of Sheffield developed a device, 3D-printed nerve
guidance conduit (NGC). NGC is a network of miniature tubes, which
guide injured nerve ends towards each other, thereby enabling them to
repair naturally. The device uses computer-aided design (CAD), which
can be modified for any type of nerve damage or even adapted for
joint specific nerves of patient.
Furthermore,
in June 2016, Polyganics, a medical device manufacturing company,
received the CE mark for Neurocap, its nerve capping device. Neurocap
is an absorbable implant for treatment and reduction of symptomatic
neuroma in peripheral nerves. The device was cleared for sales in the
U.S. in January 2016.
Nerve
Biologic Products Market – Regional Analysis
On
the basis of region, the global nerve biologic products market is
segmented into North America, Latin America, Europe, Asia Pacific,
Middle East, and Africa.
Based
on region, North America is expected to hold lead position in the
global nerve biologic products market during the forecast period,
owing to rising number of peripheral nerve injuries in the U.S. For
instance, according to Proceedings of the National Academy of
Sciences of the U.S. study in June 2017, over 250,000 people from the
U.S. suffers from peripheral nerve injury annually.
Key
Players
Key
players operating in the global nerve biologic products market
include, Stryker, AxoGen, Inc., Integra LifeSciences, Collagen
Matrix, Inc., Polyganics, Checkpoint Surgical Inc., and TEXAS
PHARMACUETICAL PVT LTD.
Nerve
Biologic Products Market – Taxonomy
By
Product Type:
-
Nerve Wraps
-
Nerve Grafts
-
Nerve Conduit
-
Nerve Capping
By
Application:
-
Nerve Grafting
-
Direct Nerve Repair/ Neurorrhaphy
-
Dural Defects
-
Peripheral Nerve Injuries
Browse
In-Depth Analysis Research Report @
https://www.coherentmarketinsights.com/ongoing-insight/nerve-biologic-products-market-2265
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm
offering action-ready syndicated research reports, custom market
analysis, consulting services, and competitive analysis through
various recommendations related to emerging market trends,
technologies, and potential absolute dollar opportunity.
Contact
Us:
Mr.
Shah
Coherent
Market Insights
1001
4th Ave,
#3200
Seattle,
WA 98154
Tel:
+1-206-701-6702
No comments:
Post a Comment